During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
B cells and T cells are important components of the adaptive immune system and mediate anti-cancer immunity. In this talk, I will present two recent studies that harness multi-omics technologies to unveil groundbreaking insights into immune cell immunosurveillance across metastatic sites and patient-specific responses to tumours. Our research reveals a dynamic co-evolution between B and T cell immune responses and metastatic cancer genomes, with B cell clones demonstrating remarkable predictability in immunosurveillance—a finding with broad relevance across immune-mediated diseases. Using single-cell multi-omics in pancreatic cancer, we identify two distinct immune microenvironments and their driving mechanisms: myeloid-enriched (linked to poor prognosis) and adaptive-enriched (associated with robust B/T cell clonal expansion and better outcomes). This work offers a novel blueprint for prioritising antibody sequences for therapeutic development and guiding rational combination immunotherapies, paving the way for more effective, personalised cancer treatments.